Chunli Wei

2.0k total citations
78 papers, 1.5k citations indexed

About

Chunli Wei is a scholar working on Molecular Biology, Genetics and Complementary and alternative medicine. According to data from OpenAlex, Chunli Wei has authored 78 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 46 papers in Molecular Biology, 18 papers in Genetics and 10 papers in Complementary and alternative medicine. Recurrent topics in Chunli Wei's work include Nigella sativa pharmacological applications (9 papers), Retinal Development and Disorders (9 papers) and Bioactive Compounds and Antitumor Agents (7 papers). Chunli Wei is often cited by papers focused on Nigella sativa pharmacological applications (9 papers), Retinal Development and Disorders (9 papers) and Bioactive Compounds and Antitumor Agents (7 papers). Chunli Wei collaborates with scholars based in China, United States and Macao. Chunli Wei's co-authors include Junjiang Fu, Jingliang Cheng, Md. Asaduzzaman Khan, Hanchun Chen, Jiewen Fu, Saber İmani, Zhiqiang Mei, Mousumi Tania, Shangyi Fu and Lianmei Zhang and has published in prestigious journals such as Cancer Research, Oncogene and Scientific Reports.

In The Last Decade

Chunli Wei

71 papers receiving 1.5k citations

Peers

Chunli Wei
Mohammad Athar United States
Yuanyuan Feng China
Daranee Chokchaichamnankit Thailand
Chang Xu China
Ana I. Faustino‐Rocha Portugal
Jorge Bouças Germany
Ashok Singh India
Lin Cheng China
Mohammad Athar United States
Chunli Wei
Citations per year, relative to Chunli Wei Chunli Wei (= 1×) peers Mohammad Athar

Countries citing papers authored by Chunli Wei

Since Specialization
Citations

This map shows the geographic impact of Chunli Wei's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chunli Wei with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chunli Wei more than expected).

Fields of papers citing papers by Chunli Wei

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chunli Wei. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chunli Wei. The network helps show where Chunli Wei may publish in the future.

Co-authorship network of co-authors of Chunli Wei

This figure shows the co-authorship network connecting the top 25 collaborators of Chunli Wei. A scholar is included among the top collaborators of Chunli Wei based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chunli Wei. Chunli Wei is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wei, Chunli, Xiaoyan Liu, Lisha Yang, et al.. (2025). Exploring breast cancer associated-gene panel for next-generation sequencing and identifying new, pathogenic variants in breast cancer from western China. Journal of Cancer. 16(4). 1281–1295. 1 indexed citations
2.
Wei, Chunli, Jisheng Zhang, Yanhua Liang, et al.. (2025). Clinical characteristics, molecular epidemiology and mechanisms of colistin heteroresistance in Enterobacter cloacae complex. Frontiers in Cellular and Infection Microbiology. 15. 1536058–1536058. 1 indexed citations
3.
Wang, Jianmin, et al.. (2025). Study on collateral sensitivity of tigecycline to colistin-resistant Enterobacter cloacae complex. Microbiology Spectrum. 13(7). e0331024–e0331024.
4.
Li, Dabing, Jingliang Cheng, Wenqian Zhang, et al.. (2024). Tripartite motif-containing 28 (TRIM28) expression and cordycepin inhibition in progression, prognosis, and therapeutics of patients with breast invasive carcinoma. Journal of Cancer. 15(13). 4374–4385. 6 indexed citations
5.
6.
7.
Tan, Qi, Chunli Wei, Hui Zou, et al.. (2023). Design, Synthesis, and Acute Toxicity Assays for Novel Thymoquinone Derivative TQFL12 in Mice and the Mechanism of Resistance to Toxicity. Molecules. 28(13). 5149–5149. 5 indexed citations
8.
Liu, Shuguang, Lisha Yang, Jiewen Fu, et al.. (2023). Comprehensive analysis, immune, and cordycepin regulation for SOX9 expression in pan-cancers and the matched healthy tissues. Frontiers in Immunology. 14. 1149986–1149986. 3 indexed citations
9.
Fu, Jiewen, et al.. (2023). New progresses on cell surface protein HSPA5/BiP/GRP78 in cancers and COVID-19. Frontiers in Immunology. 14. 1166680–1166680. 31 indexed citations
10.
Wei, Chunli, Yun Liu, Xiaoyan Liu, et al.. (2022). The speckle-type POZ protein (SPOP) inhibits breast cancer malignancy by destabilizing TWIST1. Cell Death Discovery. 8(1). 389–389. 12 indexed citations
11.
Wei, Chunli, Md. Asaduzzaman Khan, Jingliang Cheng, et al.. (2022). Cordycepin Inhibits Triple-Negative Breast Cancer Cell Migration and Invasion by Regulating EMT-TFs SLUG, TWIST1, SNAIL1, and ZEB1. Frontiers in Oncology. 12. 898583–898583. 32 indexed citations
12.
Zhang, Lianmei, Chunli Wei, Dabing Li, et al.. (2022). COVID-19 receptor and malignant cancers: Association of CTSL expression with susceptibility to SARS-CoV-2. International Journal of Biological Sciences. 18(6). 2362–2371. 23 indexed citations
13.
Cheng, Jingliang, Shangyi Fu, Jiewen Fu, et al.. (2021). Prostate adenocarcinoma and COVID‐19: The possible impacts of TMPRSS2 expressions in susceptibility to SARS‐CoV‐2. Journal of Cellular and Molecular Medicine. 25(8). 4157–4165. 25 indexed citations
14.
Fu, Jiewen, Chunli Wei, Jiayue He, et al.. (2021). Evaluation and characterization of HSPA5 (GRP78) expression profiles in normal individuals and cancer patients with COVID-19. International Journal of Biological Sciences. 17(3). 897–910. 32 indexed citations
15.
Fu, Junjiang, et al.. (2020). Epigenetic modification and a role for the E3 ligase RNF40 in cancer development and metastasis. Oncogene. 40(3). 465–474. 31 indexed citations
16.
Liu, Xiaoyan, Jingliang Cheng, Zhiqiang Mei, et al.. (2020). SCAR marker for identification and discrimination of specific medicinal Lycium chinense Miller from Lycium species from ramp-PCR RAPD fragments. 3 Biotech. 10(8). 334–334. 13 indexed citations
17.
Cheng, Jingliang, Jiewen Fu, Md. Asaduzzaman Khan, et al.. (2019). Identification of a novel germline BRCA2 variant in a Chinese breast cancer family. Journal of Cellular and Molecular Medicine. 24(2). 1676–1683. 21 indexed citations
18.
Fan, Xing‐Xing, Elaine Lai‐Han Leung, Ying Xie, et al.. (2017). Suppression of Lipogenesis via Reactive Oxygen Species–AMPK Signaling for Treating Malignant and Proliferative Diseases. Antioxidants and Redox Signaling. 28(5). 339–357. 45 indexed citations
19.
Zhu, Li, Jingliang Cheng, Chunli Wei, et al.. (2017). Diagnosis for choroideremia in a large Chinese pedigree by next-generation sequencing (NGS) and non-invasive prenatal testing (NIPT). Molecular Medicine Reports. 15(3). 1157–1164. 18 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Mohammad Athar Breakdown of academic impact, for papers by Yuanyuan Feng Breakdown of academic impact, for papers by Daranee Chokchaichamnankit Breakdown of academic impact, for papers by Chang Xu Breakdown of academic impact, for papers by Ana I. Faustino‐Rocha Breakdown of academic impact, for papers by Jorge Bouças Breakdown of academic impact, for papers by Ashok Singh Breakdown of academic impact, for papers by Lin Cheng
Rankless by CCL
2026